SANUWAVE Health (SNWV) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.88% |
| Dec 31, 2025 | 30.05% |
| Sep 30, 2025 | 52.51% |
| Jun 30, 2025 | 161.01% |
| Mar 31, 2025 | 128.75% |
| Dec 31, 2024 | 98.37% |
| Sep 30, 2024 | 116.31% |
| Jun 30, 2024 | 86.55% |
| Mar 31, 2024 | 100.64% |
| Dec 31, 2023 | 72.58% |
| Sep 30, 2023 | 52.74% |
| Jun 30, 2023 | 59.48% |
| Mar 31, 2023 | 58.94% |
| Dec 31, 2022 | 75.08% |
| Sep 30, 2022 | 91.54% |
| Jun 30, 2022 | 103.57% |
| Mar 31, 2022 | 84.47% |
| Dec 31, 2021 | 45.75% |
| Sep 30, 2021 | 70.88% |
| Jun 30, 2021 | 66.89% |
| Mar 31, 2021 | 47.21% |
| Dec 31, 2020 | 57.50% |
| Sep 30, 2020 | 56.91% |
| Jun 30, 2020 | -19.13% |
| Mar 31, 2020 | -6.67% |
| Dec 31, 2019 | 7.27% |
| Sep 30, 2019 | -2.77% |
| Jun 30, 2019 | 5.89% |
| Mar 31, 2019 | 4.17% |
| Dec 31, 2018 | 9.53% |
| Sep 30, 2018 | 32.04% |
| Jun 30, 2018 | 23.06% |
| Mar 31, 2018 | 11.34% |
| Dec 31, 2017 | 17.36% |
| Sep 30, 2017 | -1.94% |
| Jun 30, 2017 | -11.99% |
| Mar 31, 2017 | -8.91% |
| Dec 31, 2016 | 23.50% |
| Sep 30, 2016 | 9.60% |
| Jun 30, 2016 | 4.43% |
| Mar 31, 2016 | 1.36% |
| Dec 31, 2015 | 14.36% |
| Sep 30, 2015 | -12.39% |
| Jun 30, 2015 | 15.41% |